New ChiNext IPOs get approval in China
(MENAFN) Three firms' initial public offerings (IPOs) on China's NASDAQ-style ChiNext platform have been approved by the country's securities regulator.
According to the China Securities Regulatory Commission, Hangzhou Bio-Sincerity Consumer Healthcare Co., Ltd., Wuhan Kotei Informatics Co., Ltd., and Henan Carve Industrial Technology Co., Ltd. will be placed upon that Shenzhen Stock Exchange's platform of development businesses, the ChiNext platform.
After consultations with stock market, the firms and their financiers should finalize the IPO
deadlines and release the proposals.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.